Announcement on Subsidiary Obtaining Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Subsidiary Obtaining Drug Registration Certificate
Filed with SSE · · 2 pages · Chinese
Release
Harbin Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Harbin Pharmaceutical
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on the Change of Quality Control Reviewer
- Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer
- Announcement on Resolutions of the 22nd Meeting of the 10th Board of Directors
- Announcement on Reduction of Shares Held by the Company in Some of Holding Subsidiaries
Later from Harbin Pharmaceutical
- Announcement on Affiliated Enterprise Obtaining Approval for Marketing of Chemical APIs
- Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
- Announcement on Resolutions of the 24th Meeting of the 10th Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Change of Accounting Policies
Follow Harbin Pharmaceutical into a list and get an email when it puts out news.
Follow Harbin Pharmaceutical